ArticleNature communications2025
Restoring flowcell type and basecaller configuration from FASTQ files of nanopore sequencing data.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epitranscriptomic control of stress adaptations in Escherichia coli.Nucleic acids research · 2026Article
- Restoring flowcell type and basecaller configuration from FASTQ files of nanopore sequencing data.Nature communications · 2025Article
- HapAsmbl: A reference-aided pipeline for assembling haplotypes in Nanopore amplicon sequence data of polymorphic populations.Applications in plant sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
As nanopore sequencing has been widely adopted, data accumulation has surged, resulting in over 700,000 public datasets. While these data hold immense potential for advancing genomic research, their utility is compromised by the absence of flowcell type and basecaller configuration in about 85% of the data and associated publications. These parameters are essential for many analysis algorithms, and their misapplication can lead to significant drops in performance. To address this issue, we present LongBow, designed to infer flowcell type and basecaller configuration directly from the base quality value patterns of FASTQ files. LongBow has been tested on 66 in-house basecalled FAST5/POD5 datasets and 1989 public FASTQ datasets, achieving accuracies of 95.33% and 91.45%, respectively. We demonstrate its utility by reanalyzing nanopore sequencing data from the COVID-19 Genomics UK (COG-UK) project. The results show that LongBow is essential for reproducing reported genomic variants and, through a LongBow-based analysis pipeline, we discovered substantially more functionally important variants while improving accuracy in lineage assignment. Overall, LongBow is poised to play a critical role in maximizing the utility of public nanopore sequencing data, while significantly enhancing the reproducibility of related research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.